| Net Cash Provided by (Used in) Operating Activities |
-35.8M |
USD |
-267% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
-224M |
USD |
+17.5% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Investing Activities |
275M |
USD |
-4.12% |
Q1 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
500M |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Common Stock, Shares, Issued |
140M |
shares |
+0.61% |
Q3 2025 |
Q3 2025 |
| Common Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
15.4M |
USD |
-58.3% |
Q1 2025 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
356M |
USD |
+147% |
Q3 2025 |
Q3 2025 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
91.9M |
USD |
-21.2% |
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Valuation Allowance |
55.6M |
USD |
+98.6% |
Q3 2025 |
Q3 2025 |
| Deferred Tax Assets, Gross |
21.7M |
USD |
+30.7% |
Q4 2023 |
FY 2023 |
| Depreciation |
5.1M |
USD |
-46.3% |
Q3 2025 |
Q3 2025 |
| Deferred Tax Assets, Operating Loss Carryforwards |
23.5M |
USD |
+32% |
Q4 2024 |
FY 2024 |
| Unrecognized Tax Benefits |
0 |
USD |
|
Q3 2025 |
Q3 2025 |
| Additional Paid in Capital |
2.75B |
USD |
+0.56% |
Q3 2025 |
Q3 2025 |
| Interest Expense |
343M |
USD |
-25.6% |
Q3 2025 |
Q3 2025 |